Advertisement

Medicine, Health Care and Philosophy

, Volume 18, Issue 4, pp 475–485 | Cite as

The ethics of deep brain stimulation (DBS)

  • Marcus Unterrainer
  • Fuat S. Oduncu
Scientific Contribution

Abstract

Deep brain stimulation (DBS) is an invasive technique designed to stimulate certain deep brain regions for therapeutic purposes and is currently used mainly in patients with neurodegenerative disorders, such as Parkinson’s disease. However, DBS is also used increasingly for other experimental applications, such as the treatment of psychiatric disorders (e.g. severe depression), weight reduction. Apart from its therapeutic potential, DBS can cause severe adverse effects, some that might also have a significant impact on the patient’s personality and autonomy by the external stimulation of DBS which effects lie beyond the individual’s control and free will. The article’s purpose is to outline the procedures of DBS currently used in therapeutic and experimental applications and to discuss the ethical concerns regarding this procedure. It will address the clinical benefit-risk-ratio, the particular ethics of research in this field, and the ethical issues raised by affecting a patient’s or an individual’s personality and autonomous behaviour. Moreover, a potential ethical guideline, the Ulysses contract is discussed for the field of clinical application as well as the question of responsibility.

Keywords

Deep brain stimulation (DBS) Ethics of DBS Ulysses contract Neuroethics Parkinson’s disease (PD) 

Notes

Acknowledgments

We would like to thank very much Dr. Todd Braciak and Alison Schulz B.Sc. for their help with editing of the manuscript as well as Prof. Dr. Michael Rust for his fruitful discussion on the paper.

References

  1. Aarsland, D., K. Andersen, J. Larsen, and A. Lolk. 2003. Prevalence and characteristics of dementia in Parkinson disease. Archives of Neurology 60(3): 387–392.CrossRefGoogle Scholar
  2. Abelson, J.L., G.C. Curtis, O. Sagher, R.C. Albucher, M. Harrigan, S.F. Taylor, B. Martis, and B. Giordani. 2004. Deep brain stimulation for refractory obsessive–compulsive disorder. Biological Psychiatry 57(5): 510–516.CrossRefGoogle Scholar
  3. Beauchamp, T.L., and R. Faden. 2004. Bedeutung und Elemente des Informierten Einverständnisses. In Ethik in der Medizin, ed. Ein Studienbuch, 111–122. U. Stuttgart: Wiesing.Google Scholar
  4. Beauchamp, T.L., and J.F. Childress. 2009. Principles of biomedical ethics. New York: Oxford University Press.Google Scholar
  5. Bejjani, B.P., P. Damier, I. Arnulf, L. Thivard, A.M. Bonnet, D. Dormont, P. Cornu, B. Pidoux, Y. Samson, and Y. Agid. 1999. Transient acute depression induced by high-frequency deep-brain stimulation. New England Journal of Medicine 340: 1476–1480.CrossRefGoogle Scholar
  6. Benabid, A.L. 2003. Deep brain stimulation for Parkinson’s disease. Current Opinion in Neurobiology 13: 696–706.CrossRefGoogle Scholar
  7. Bublitz, J.C., and R. Merkel. 2009. Autonomy and authenticity of enhanced personality traits. Bioethics 23(6): 360–374.CrossRefGoogle Scholar
  8. Carter, A., and W. Hall. 2013. Managing suicide risk in experimental treatments of treatment-resistant depression. AJOB Neuroscience 4(1): 38–39.CrossRefGoogle Scholar
  9. Clausen, J. 2009a. Man, machine and in between. Nature 457(7233): 1080–1081.CrossRefGoogle Scholar
  10. Clausen, J. 2009b. Tiefenhirnstimulation. Wo liegen die Grenzen des ethisch Vertretbaren? Ärzteblatt Baden- Württemberg 64(5): 203–206.Google Scholar
  11. Clausen, J. 2011. Conceptual and ethical issues with brain–hardware devices. Current Opinion in Psychiatry 24(6): 495–501.Google Scholar
  12. Copeland, S.M. 2013. Problems with seeing DBS recipients primarily as research subjects. AJOB Neuroscience 4(2): 50–52.CrossRefGoogle Scholar
  13. Deuschl, G., and S. Franke. 2007. Tiefe Hirnstimulation bei fortgeschrittener Parkinson-Erkrankung [Deep brain stimulation in therapy of advanced Parkinson’s disease]. Nervernheilkunde 26(4): 251–255.Google Scholar
  14. Dubiel, H. 2006. Tief im Hirn. München: Kunstmann.Google Scholar
  15. Düwell, M. 2008. Bioethik – Methoden. Stuttgart: Theorien und Bereiche.Google Scholar
  16. Dworkin, G. 1988. The theory and practice of autonomy. Cambridge: Cambridge University Press.CrossRefGoogle Scholar
  17. Dworkin, G. 1997. Paternalism. In Mills on liberty: Critical essays, ed. G. Dworkin, 61–82. Lanham: Rowman & Littlefield.Google Scholar
  18. Emanuel, E.J., D. Wendler, and C. Grady. 2000. What makes clinical research ethical? JAMA 283: 2701–2711.CrossRefGoogle Scholar
  19. Emanuel, L.L., M.J. Barry, J.D. Stoeckle, et al. 1991. Advance directives for medical care: A case for greater use. New England Journal of Medicine 324: 889–895.CrossRefGoogle Scholar
  20. Focquaert, F. 2013. Deep brain stimulation in children: Parental authority versus shared decision-making. Neuroethics 6(3): 447–455.CrossRefGoogle Scholar
  21. Ford, P.J., and C.S. Kubu. 2006. Stimulating debate: Ethics in a multidisciplinary functional neurosurgery committee. Journal of Medical Ethics 32: 106–109.CrossRefGoogle Scholar
  22. Frankfurt, H. 2001. Willensfreiheit und der Begriff der Person. In Harry FrankfurtFreiheit und Selbstbestimmung, eds. Betzler, M. and B. Guckes, 65–84. Berlin: Akademie Verlag.Google Scholar
  23. Gabriëls, L., P. Cosyns, B. Nuttin, H. Demeulemeester, and J. Gybels. 2003. Deep brain stimulation for treatment-refractory obsessive–compulsive disorder: Psychopathological and neuropsychological outcome in three cases. Acta Psychiatrica Scandinavica 107(4): 275–282.CrossRefGoogle Scholar
  24. Gilbert, F. 2013. Deep brain stimulation for treatment resistant depression: Postoperative feelings of self-estrangement, suicide attempt and impulsive–aggressive behaviours. Neuroethics 6(3): 473–481.CrossRefGoogle Scholar
  25. Goethals, I., F. Jacobs, C. Van der Linden, J. Caemaert, and K. Audenaert. 2008. Brain activation associated with deep brain stimulation causing dissociation in a patient with Tourette’s syndrome. Journal of Trauma & Dissociation 9(4): 543–549.CrossRefGoogle Scholar
  26. Gleixner, C., M. Müller and S. Wirth. 2011. Neurologie und Psychiatrie, Medizinische Vlgs- u. Inform.-Dienste.Google Scholar
  27. Greenberg, B.D., K.D. Askland, and L.L. Carpenter. 2008. The evolution of deep brain stimulation for neuropsychiatric disorders. Frontiers in Bioscience: A Journal and Virtual Library 13: 4638–4648.CrossRefGoogle Scholar
  28. Grill, W.M. 2005. Safety considerations for deep brain stimulation: Review and analysis. Expert Review of Medical Devices 2: 409–420.CrossRefGoogle Scholar
  29. Halpern, C.H., J.A. Wolf, T.L. Bale, et al. 2008. Deep brain stimulation in the treatment of obesity: A review. Journal of Neurosurgery 109(10): 625–634.CrossRefGoogle Scholar
  30. Hamani, C., M. Hodaie, and A.M. Lozano. 2005. Present and future of deep brain stimulation for refractory epilepsy. Acta Neurochirurgica 147: 227–229.CrossRefGoogle Scholar
  31. Hamani, C., J.M. Schwalb, A.R. Rezai, J.O. Dostrovsky, K.D. Davis, and A.M. Lozano. 2006. Deep brain stimulation for chronic neuropathic pain: Long-term outcome and the incidence of insertional effect. Pain 125(1–2): 188–196.CrossRefGoogle Scholar
  32. Helmchen, H., and H. Lauter. 1995. Dürfen Ärzte mit Demenzkranken forschen?. Stuttgart: Analyse des Problemfeldes Forschungsbedarf und Einwilligungsproblematik.Google Scholar
  33. Hildt, E. 2008. Autonomie in der Medizin – Selbstbestimmung, Selbstentwurf und Lebensgestaltung. Bundesgesundheitsblatt - Gesundheitsforschung – Gesundheitsschutz 51: 827–834.CrossRefGoogle Scholar
  34. Hildt, E. 2009. Fremdes im Gehirn. In Der implantierte MenschTherapie und Enhancement im Gehirn, eds. Hildt, E. and E. Engels, 105–128. Freiburg/München: Verlag Karl Alber.Google Scholar
  35. Houeto, J.L., V. Mesnage, L. Mallet, B. Pillon, M. Gargiulo, S.T. du Moncel, A.M. Bonnet, B. Pidoux, D. Dormont, P. Cornu, and Y. Agid. 2002. Behavioural disorders, Parkinson’s disease and subthalamic stimulation. Journal of Neurology, Neurosurgery and Psychiatry 72(6): 701–707.CrossRefGoogle Scholar
  36. Johansson, V., M. Garwicz, M. Kanje, H. Röcklinsberg, J. Schouenborg, A. Tingström, and U. Görman. 2013. Beyond blind optimism and unfounded fears: Deep brain stimulation for treatment resistant depression. Neuroethics 6(3): 457–471.CrossRefGoogle Scholar
  37. Klaming, L., and P. Haselager. 2013. Did my brain implant make me do it? Questions raised by DBS regarding psychological continuity, responsibility for action and mental competence. Neuroethics 6(3): 527–539.CrossRefGoogle Scholar
  38. Krack, P., R. Kumar, C. Ardouin, P.L. Dowsey, J.M. McVicker, A.L. Benabid, and P. Pollak. 2001. Mirthful laughter induced by subthalamic nucleus stimulation. Movement Disorders 16: 867–875.CrossRefGoogle Scholar
  39. Kraemer, F. 2013. Me, myself and my brain implant: Deep brain stimulation raises questions of personal authenticity and alienation. Neuroethics 6(3): 483–497.CrossRefGoogle Scholar
  40. Kuhn, J., D. Lenartz, W. Huff, et al. 2007. Remission of alcohol dependency following deep brain stimulation of the nucleus accumbens: Valuable therapeutic implications? Journal of Neurology, Neurosurgery and Psychiatry 78(10): 1152–1153.CrossRefGoogle Scholar
  41. Kulisevsky, J., M.L. Berthier, A. Gironell, B. Pascual-Sedano, J. Molet, and P. Pares. 2002. Mania following deep brain stimulation for Parkinson’s disease. Neurology 59: 1421–1424.CrossRefGoogle Scholar
  42. Leone, M., A. Proietti Cecchini, A. Franzini, G. Broggi, P. Cortelli, P. Montagna, and G. Bussone. 2008. LKessons from 8 years' experience of hypothalamic stimulation in cluster headcache. Cephalalgia 28(7): 787–797.Google Scholar
  43. Lüllmann, H. 2010. Pharmakologie und Toxikologie. Stuttgart: Thieme Verlag.CrossRefGoogle Scholar
  44. Machado, A., A. Rezai, B. Kopell, R. Gross, A. Sharan, and A.L. Benabid. 2006. Deep brain stimulation for Parkinson’s disease: Surgical technique and perioperative management. Movement Disorders 21(14): 247–258.CrossRefGoogle Scholar
  45. Mandat, T.S., T. Hurwitz, and C.R. Honey. 2006. Hypomania as an adverse effect of subthalamic nucleus stimulation: Report of two cases. Acta Neurochirurgica 148: 895–897. discussion 898.CrossRefGoogle Scholar
  46. Mantione, M., W. van der Brink, P.R. Schuurman, and D. Denys. 2010. Smoking cessation and weight loss after chronic deep brain stimulation of the nucleus accumbens: Therapeutic and research implications: Case report. Neurosurgery 66(1): E218.CrossRefGoogle Scholar
  47. Mayberg, H.S., A.M. Lozano, V. Voon, H.E. McNeely, D. Seminowicz, C. Hamani, J.M. Schwalb, and S.H. Kennedy. 2005. Deep brain stimulation for treatment-resistant depression. Neuron 45: 651–660.CrossRefGoogle Scholar
  48. Menza, M., R.D. Dobkin, H. Marin, M.H. Mark, M. Gara, S. Buyske, K. Bienfait, and A. Dicke. 2008. A controlled trial of antidepressants in patients with Parkinson disease and depression. Neurology 72(10): 886–892.CrossRefGoogle Scholar
  49. Merkel, R., G. Boer, J. Fegert, T. Galert, D. Hartmann, B. Nuttin, and S. Rosahl. 2007. Intervening in the Brain. Berlin: Changing Psyche and Society.Google Scholar
  50. Mesnage, V., J.L. Houeto, M.L. Welter, Y. Agid, et al. 2002. Parkinson’s disease: Neurosurgery at an earlier stage? Journal of Neurology, Neurosurgery and Psychiatry 73(6): 778–779.CrossRefGoogle Scholar
  51. Pierce, R. 2014. Broader challenges for DBS in the treatment of Alzheimer’s disease. AJOB Neuroscience 5(4): 81–83.CrossRefGoogle Scholar
  52. Schermer, M. 2013. Health, happiness and human enhancement—Dealing with unexpected effects of deep brain stimulation. Neuroethics 6(3): 435–445.CrossRefGoogle Scholar
  53. Schiff, N.D., J.T. Giacino, K. Kalmar, J.D. Victor, K. Baker, M. Gerber, B. Fritz, B. Eisenberg, J. O’Connor, E.L. Kobylarz, S. Farris, A. Machado, C. McCagg, F. Plum, J.J. Fins, and A.R. Rezai. 2007. Behavioural improvements with thalamic stimulation after severe traumatic brain injury. Nature 448: 600–603.CrossRefGoogle Scholar
  54. Schlaepfer, T.E., M.X. Cohen, C. Frick, M. Kosel, et al. 2007. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 33(2): 368–377.CrossRefGoogle Scholar
  55. Schöne-Seifert, B. 2007. Grundlagen der Medizinethik. Stuttgart: Kröner.Google Scholar
  56. Schrag, A. 2004. Psychiatric aspects of Parkinson’s disease—An update. Journal of Neurology 251: 795–804.CrossRefGoogle Scholar
  57. Schüpbach, W.M., D. Maltête, J.L. Houeto, et al. 2007. Neurosurgery at an earlier stage of Parkinson disease: A randomized, controlled trial. Neurology 68(4): 267–271.CrossRefGoogle Scholar
  58. Sensi, M., R. Eleopra, M.A. Cavallo, E. Sette, P. Milani, R. Quatrale, J.G. Capone, V. Tugnoli, M.R. Tola, E. Granieri, and P.G. Data. 2004. Explosive–aggressive behavior related to bilateral subthalamic stimulation. Parkinsonism & Related Disorders 10(4): 247–251.CrossRefGoogle Scholar
  59. Soulas, T., J.M. Gurruchaga, S. Palfi, P. Cesaro, J.P. Nguyen, and G. Fenelon. 2008. Attempted and completed suicides after subthalamic nucleus stimulation for Parkinson’s disease. Journal of Neurology, Neurosurgery and Psychiatry 79(8): 952–954.CrossRefGoogle Scholar
  60. Starr, P.A., J.L. Vitek, and R.A.E. Bakay. 1998. Deep brain stimulation for movement disorders. Neurosurgery Clinics of North America 9: 381–404.Google Scholar
  61. Synofzyk, M., and T.E. Schlaepfer. 2008. Stimulating personality: Ethical criteria for deep brain stimulation in psychiatric patients and for enhancement purposes. Journal of Biotechnology 3: 1511–1520.CrossRefGoogle Scholar
  62. Talbot, D. 2009. Tiefenhirnstimulation und Autonomie. In Das technisierte GehirnNeurotechnologie als Herausforderung für Ethik und Anthropologie, eds. Müller, O., J. Clausen and G. Maio, 165–186. Paderborn.Google Scholar
  63. Van Willigenburg, T., and P. Delaere. 2005. Protecting autonomy as authenticity using Ulysses contracts. Journal of Medicine and Philosophy 30: 395–409.CrossRefGoogle Scholar
  64. Voon, V., P. Krack, A.E. Lang, A.M. Lozano, K. Dujardin, M. Schüpbach, J. D’Ambrosia, S. Thobois, F. Tamma, J. Herzog, J.D. Speelman, J. Samanta, C. Kubu, H. Rossignol, Y.Y. Poon, J.A. Saint-Cyr, C. Ardouin, E. Moro, and E. Moro. 2008. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson’s disease. Brain 131(10): 2720–2728.CrossRefGoogle Scholar
  65. Weaver, F.M., K. Follett, M. Stern, K. Hur, et al. 2009. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: A randomized controlled trial. JAMA 301(1): 63–73.CrossRefGoogle Scholar
  66. Winner, B. and J. Winkler. 2009. Adulte neuronale Stammzellen: Therapiekonzept in der Neurologie. In Der implantierte Mensch – Therapie und Enhancement im Gehirn, eds. Hildt, E. and E. Engels, 53–64. Freiburg/München: Verlag Karl Alber.Google Scholar
  67. WMA, World Medical Association Declaration of Helsinki. 2008. Ethical Principles for Medical Re-search Involving Human Subjects. www.wma.net/en/30/publications/10policies/b3/17c.pdf. Accessed 15 Jan 2015.
  68. Witt, K. 2013. Das Identitätsproblem der tiefen Hirnstimulation und einige seiner praktischen Implikationen. Ethik in der Medizin 25(1): 5–18.CrossRefGoogle Scholar
  69. Yamamoto, T., K. Kobayashi, M. Kasai, H. Oshima, C. Fukaya, and Y. Katayama. 2005. DBS therapy for the vegetative state and minimally conscious state. Acta Neurochirurgica 93: 101–104.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2015

Authors and Affiliations

  1. 1.Medical Faculty of the University of MunichMunichGermany
  2. 2.Division of Hematology and Oncology, Medizinische Klinik und Poliklinik IVKlinikum der Universität MünchenMunichGermany

Personalised recommendations